Catalyst Pharmaceuticals Inc. (CN2)
Market Closed
24 Feb, 20:00
XFRA 
€
20. 17
+0.02
+0.1%
€
- Market Cap
24.43 P/E Ratio
- Div Yield
0 Volume
1 Eps
€ 20.15
Previous Close Day Range
20.17 20.17
Year Range
16.15 24
Want to track CN2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CN2 earnings report is expected in 1 days (25 Feb 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.5 | - |
| | | 0.54 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CN2 Earnings Reports FAQ
What is the earnings per share (EPS) for CN2?
The current EPS is 1.
What is the company's earnings growth rate?
Catalyst Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-25, based on the CN2's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Catalyst Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CN2 at this time, as Catalyst Pharmaceuticals Inc has no recent EPS data to calculate it.
